Market Overview

Barclays On Eurobanks: UBS Upgraded, Credit Suisse, Deutsche Bank Downgraded

Share:
Barclays On Eurobanks: UBS Upgraded, Credit Suisse, Deutsche Bank Downgraded
Related CS
25 Stocks Moving In Wednesday's Pre-Market Session
Jim Cramer Gives His Opinion On Lockheed Martin, Procter & Gamble And Credit Suisse
Related DB
Fintech Wizard Yin Luo Mines The Human Language For Hidden Meanings
A Short-Term Way To Play The Turnaround In European Banks

Litigation continues to be “a live issue” for the large European investment banks, with major cases in the pipeline and potential settlements in the coming months, Barclays’ Jeremy Sigee said in a report. He added that the upcoming litigation settlements could be large and trigger capital raising.

Credit Suisse Group AG (ADR) (NYSE: CS) and Deutsche Bank AG (USA) (NYSE: DB) have been downgraded from Overweight to Equal Weight. The price target for Credit Suisse has been reduced from $19 to $14, while that for Deutsche Bank is down from $28 to $16.50.

Related Link: What U.K. ETFs Are Saying About Brexit

Both Credit Suisse and Deutsche Bank face the risk of the litigations further aggravating “already delicate earnings and capital positions,” and they could potentially lead to equity raising measures, Sigee commented. Meanwhile, their operational performances and restructuring efforts remain under pressure and their turnarounds could be delayed beyond the planned 2016 timelines.

The analyst upgraded the rating for UBS Group AG (USA) (NYSE: UBS) from Equal Weight to Overweight, while reducing the price target from $21 to $17. He said that UBS seems to be much more resilient against these risks.

Impact Of Largest Litigation

The analyst said that the largest and most imminent litigation exposure appears to be US RMBS. He estimated central case settlement amounts of $4.5bn for Deutsche Bank and $2bn each for Credit Suisse and UBS.

Latest Ratings for CS

DateFirmActionFromTo
Dec 2016JP MorganUpgradesUnderweightOverweight
Nov 2016Bank of AmericaUpgradesNeutralBuy
Nov 2016MacquarieDowngradesOutperformNeutral

View More Analyst Ratings for CS
View the Latest Analyst Ratings

Posted-In: BarclaysAnalyst Color Long Ideas Upgrades Downgrades Price Target Analyst Ratings Trading Ideas Best of Benzinga

 

Related Articles (CS + DB)

View Comments and Join the Discussion!